Phenytoin (Epilepsy) updated on 12-01-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.97 [1.33, 2.92]29%19 studies3911,412probable ROB3.36 [2.00; .]
Major congenital malformations1.46 [0.98, 2.16]13%13 studies2821,167low ROB-
Congenital heart defects2.10 [0.93, 4.72]41%9 studies65875not evaluable ROB-
Limb defects2.20 [0.64, 7.52]0%5 studies14290not evaluable ROB-
Neural Tube Defects3.20 [0.89, 11.45]0%6 studies8694not evaluable ROB-
Cleft lip with or without cleft palate5.07 [0.94, 27.30]0%5 studies3113not evaluable ROB-
Hypospadias0.75 [0.22, 2.57]0%5 studies18666serious ROB-
Microcephaly / Small head circumference for gestational age0.69 [0.30, 1.60]0%5 studies24297not evaluable ROB-
Polydactyly2.60 [0.22, 30.36]45%4 studies3168not evaluable ROB-
Spina bifida3.70 [0.29, 47.79]46%4 studies2101not evaluable ROB-
Urinary malformations1.17 [0.16, 8.76]27%3 studies15282not evaluable ROB-
Digestive system anomalies1.88 [0.29, 12.03]0%2 studies5201not evaluable ROB-
Minor congenital malformations1.90 [0.62, 5.84]32%3 studies2973not evaluable ROB-
Oro-facial clefts1.91 [0.55, 6.62]0%3 studies14623not evaluable ROB-
Cleft palate4.13 [0.07, 229.95]48%2 studies122not evaluable ROB-
Craniosynostosis1.92 [0.08, 44.92]-1 study222not evaluable ROB-
Down syndrom / Trisomy 211.10 [0.04, 30.00]-1 study122not evaluable ROB-
Eye defects1.75 [0.31, 9.77]24%2 studies1162not evaluable ROB-
Hip dislocation and/or dysplasia1.10 [0.04, 30.00]-1 study122not evaluable ROB-
Nervous system anomalies8.67 [0.35, 214.26]-1 study1119not evaluable ROB-
Chromosomal abnormalities25.03 [0.49, 1278.58]-1 study38not evaluable ROB-
Club foot / Talipes equinovarus0.57 [0.01, 30.76]-1 study120not evaluable ROB-
Ear, face and neck anomalies4.99 [0.24, 105.88]-1 study238not evaluable ROB-
Genital anomalies2.26 [0.12, 41.69]-1 study538not evaluable ROB-

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Preterm (< 37 weeks)2.11 [0.93, 4.81]0%5 studies107100not evaluable ROB-
Small for gestational age (weight)0.92 [0.45, 1.87]0%4 studies2,429142not evaluable ROB-
Large for gestational age (weight)3.81 [0.42, 34.93]25%2 studies7427not evaluable ROB-
Low birth weight (< 2500g)1.94 [0.76, 4.95]-1 study1,01264not evaluable ROB-
Large head circumference for gestational age0.37 [0.01, 20.14]-1 study21not evaluable ROB-

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Caesarean0.19 [0.03, 1.30]-1 study33226not evaluable ROB-
Amniotic fluid problems (polyhydramnios and/or oligohydramnios)43.00 [0.35, 5328.22]-1 study1not evaluable ROB-
Gestational diabetes13.67 [0.19, 964.02]-1 study11not evaluable ROB-
Preeclampsia43.00 [0.35, 5328.22]-1 study1not evaluable ROB-

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Neonatal medical care1.37 [0.26, 7.15]1%4 studies1,97846not evaluable ROB-
Low Apgar score (< 7) (at 1 min)2.56 [0.32, 20.32]51%2 studies8374not evaluable ROB-
Low Apgar score (< 7) (at 5 min)22.18 [2.31, 213.27]0%2 studies555not evaluable ROB43.86 [4.04; .]
Feeding difficulty1.79 [0.18, 18.25]0%2 studies234not evaluable ROB-
Jaundice / Icterus0.70 [0.05, 8.97]-1 study322not evaluable ROB-
Neonatal disorders (as a whole)3.00 [0.49, 18.25]-1 study1322not evaluable ROB-
Neonatal hypotonia1.92 [0.08, 44.92]-1 study222not evaluable ROB-
Neonatal infections1.10 [0.04, 30.00]-1 study122not evaluable ROB-
Neonatal intracranial hemorrhage1.10 [0.04, 30.00]-1 study122not evaluable ROB-
Neonatal tachypnea0.35 [0.01, 19.18]-1 study22not evaluable ROB-
Withdrawal syndrome / Neonatal abstinence syndrome / Poor neonatal adaptation--0 study-

Long term consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Child/Infant death (> 28 days of life)6.37 [0.34, 118.32]-1 study526not evaluable ROB-
Child/Infant growth abnormalities (> 1 year)0.74 [0.17, 3.12]-1 study945not evaluable ROB-
Child/Infant head circumference abnormalities (> 1 year)4.48 [0.18, 112.88]-1 study140not evaluable ROB-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Intrauterine deaths (as a whole or unspecified)5.01 [1.66, 15.13]0%5 studies19218not evaluable ROB9.49 [2.70; .]
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions1.73 [0.12, 25.30]0%2 studies26not evaluable ROB-
Perinatal death2.05 [0.20, 20.82]0%2 studies1057not evaluable ROB-
Elective/induced termination of pregnancy7.00 [0.05, 953.26]-1 study1not evaluable ROB-
Late intrauterine deaths (> 22 weeks) / Stillbirths12.49 [0.56, 277.13]0%2 studies6not evaluable ROB-
Therapeutic terminations of pregnancy7.00 [0.05, 953.26]-1 study1not evaluable ROB-

Neuro-developmental disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Cognitive developmental disorders/delay (> 6 years old)1.07 [0.58, 1.98]28%7 studies18315not evaluable ROB-
ASD (Autism spectrum disorder): Diagnosis1.34 [0.37, 4.89]41%3 studies433201not evaluable ROB-
ASD (Autism spectrum disorder): Diagnosis/Risk1.34 [0.37, 4.89]41%3 studies433201not evaluable ROB-
Cognitive developmental disorders/delay (< 3 years old)1.36 [0.56, 3.32]66%4 studies31185not evaluable ROB-
Language disorders/delay0.99 [0.61, 1.63]0%4 studies6111not evaluable ROB-
Neuro-developmental disorders (as a whole)2.37 [0.65, 8.62]47%4 studies5157not evaluable ROB-
Severe cognitive developmental delay (Mental retardation) (> 6 years old)0.87 [0.32, 2.32]0%4 studies14244not evaluable ROB-
ADHD (Attention deficit hyperactivity disorder): Diagnosis1.15 [0.77, 1.72]0%3 studies957209not evaluable ROB-
ADHD (Attention deficit hyperactivity disorder): Diagnosis/Risk1.15 [0.77, 1.72]0%3 studies957209not evaluable ROB-
Psychomotor developmental disorders/delay0.90 [0.59, 1.38]0%3 studies5123not evaluable ROB-
Learning disorders 0.88 [0.53, 1.47]-1 study76288not evaluable ROB-
ADHD (Attention deficit hyperactivity disorder): Risk0.53 [0.10, 2.73]-1 study931not evaluable ROB-
Cognitive developmental disorders/delay (3-6 years old)1.15 [0.30, 4.31]-1 study1043not evaluable ROB-
Severe cognitive developmental delay (Mental retardation) (< 3 years old)1.40 [0.40, 4.90]-1 study1142not evaluable ROB-
Severe cognitive developmental delay (Mental retardation) (3-6 years old)1.71 [0.03, 87.56]-1 study43not evaluable ROB-

Hide endpoints reported in only one study ...

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons